Skip to content
★ Sign in to follow
WJ
Total declarations
150
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (60 ops.)
€24.1M

Latest filing published 29 May 2019 for ABIOMED INC, €348k.

Filing timeline

BuySale
William J. Bolt

Insider track record

Disclosed buys
0
Disclosed sells
60
Signal history

William J. Bolt: trading record in brief

William J. Bolt appears in our data through filings on Abiomed Inc shares, published by SEC (Form 4). We count 150 filings; the first trade dates from 2 June 2006 and the latest from 24 May 2019.

The open-market record consists of 60 sales worth €24.1M, with no purchase. Outside the open market, there are 59 share grants and 30 option exercises.

On 29 May 2019 came the latest disclosure, a share grant for €348k in Abiomed Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to William J. Bolt

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations150 total
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    389,495 USD11SEC
    1,483 shares@ US$262.643.6% of flowCommon Stock, $.01 parSEC:0001179110-19-006783:0
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    0SEC
    2,786 shares0Common Stock, $.01 parSEC:0001179110-19-006281:2
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    304,178 USD11SEC
    1,185 shares@ US$256.692.8% of flowCommon Stock, $.01 parSEC:0001179110-19-006281:0
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    76,237 USD11SEC
    297 shares@ US$256.690.7% of flowCommon Stock, $.01 parSEC:0001179110-19-006281:1
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    54,013 USD11SEC
    208 shares@ US$259.680.5% of flowCommon Stock, $.01 parSEC:0001179110-19-006281:3
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    107,508 USD11SEC
    414 shares@ US$259.681.0% of flowCommon Stock, $.01 parSEC:0001179110-19-006281:4
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    0SEC
    56 shares0Common Stock, $.01 parSEC:0001179110-19-004531:0
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    586,952 USD11SEC
    1,484 shares@ US$395.522.5% of flowCommon Stock, $.01 parSEC:0001179110-18-007555:0
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    0SEC
    1,400 shares0Common Stock, $.01 parSEC:0001179110-18-007132:0
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    0SEC
    8,000 shares0Common Stock, $.01 parSEC:0001179110-18-006918:1
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    719,272 USD11SEC
    1,930 shares@ US$372.683.0% of flowCommon Stock, $.01 parSEC:0001179110-18-006918:0
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    557,494 USD11SEC
    1,484 shares@ US$375.672.4% of flowCommon Stock, $.01 parSEC:0001179110-18-006918:2
  • ◇
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    165,967 USD11SEC
    1,666 shares@ US$99.620.7% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:0
  • ◇
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    265,000 USD11SEC
    4,000 shares@ US$66.251.1% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:1
  • ◇
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    107,750 USD11SEC
    5,000 shares@ US$21.550.5% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:2
  • ◇
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    115,750 USD11SEC
    5,000 shares@ US$23.150.5% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:3
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    533,349 USD29SEC
    1,545 shares@ US$345.212.3% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:4
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    919,161 USD29SEC
    2,655 shares@ US$346.203.9% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:5
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    2M USD30SEC
    5,408 shares@ US$347.028.0% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:6
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    944,070 USD29SEC
    2,713 shares@ US$347.984.0% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:7
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    3M USD30SEC
    7,901 shares@ US$349.0611.7% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:8
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    350,010 USD29SEC
    1,000 shares@ US$350.011.5% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:9
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    480,086 USD29SEC
    1,368 shares@ US$350.942.0% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:10
  • ▼
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    70,432 USD29SEC
    200 shares@ US$352.160.3% of flowCommon Stock, $.01 parSEC:0001179110-18-006500:11
  • ◆
    SVP, QA and Regulatory AffairsExecutivesAbiomed Inc
    24,734 USD11SEC
    85 shares@ US$290.990.1% of flowCommon Stock, $.01 parSEC:0001179110-18-005200:0

25 of 150 declarations